H-1B sponsorCAFEIN 27-0557891Updated Jun 2026
PharmaCare U.S., Inc.
US H-1B Labor Condition Application activity for PharmaCare U.S., Inc.. Filed 386 disclosures between FY2010 and FY2025 from worksites with a CA headquarters indicator.
Total filings
1
Outside top-N · FY2025
Certified
100.0%
unconditional · FY2025
Withdrawn
0.0%
withdrawn rate · FY2025
Denied
0.0%
rejection rate · FY2025
Outcome breakdown
Share of PharmaCare U.S., Inc.’s LCAs by DOL case status, all fiscal years. Use the year filter above for a single-year breakdown.
Certified66.7%
Cert-withdrawn33.3%
Top occupations sponsored
SOC codes filed most by PharmaCare U.S., Inc. across all fiscal years. Click any row to open the national salary guide.
| # | SOC | Title | Filings |
|---|---|---|---|
| 1 | 19-2031 | Chemists | 136 |
| 2 | 29-1051 | Pharmacists | 68 |
| 3 | 19-4021 | Biological Technicians | 28 |
| 4 | 15-1253 | Software Quality Assurance Analysts and Testers | 17 |
| 5 | 13-1041 | Compliance Officers | 13 |
| 6 | 15-2031 | Operations Research Analysts | 13 |
| 7 | 19-1022 | Microbiologists | 12 |
| 8 | 11-3021 | Computer and Information Systems Managers | 9 |
| 9 | 17-2112 | Industrial Engineers | 8 |
| 10 | 15-1244 | Network and Computer Systems Administrators | 8 |
Chemists
136
Pharmacists
68
Biological Technicians
28
Software Quality Assurance Analysts and Testers
17
Compliance Officers
13
Operations Research Analysts
13
Microbiologists
12
Computer and Information Systems Managers
9
Industrial Engineers
8
Network and Computer Systems Administrators
8
Filings by fiscal year
Year-over-year H-1B filing volume — a hiring-demand signal, not headcount.
| Year | Filings |
|---|---|
| FY2010 | 35 |
| FY2011 | 53 |
| FY2012 | 49 |
| FY2013 | 63 |
| FY2014 | 38 |
| FY2015 | 42 |
| FY2016 | 30 |
| FY2017 | 24 |
| FY2018 | 29 |
| FY2019 | 20 |
| FY2020 | 2 |
| FY2025 | 1 |
Compare PharmaCare U.S., Inc. with another sponsor
Side-by-side view of KPIs, outcomes, top breakdowns and yearly trend.
Explore by rank
Pre-built leaderboards for the most-asked questions.